Validation pour Ingenuity294

vers la météo de la validation par utilisateur

Ingenuity294

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 0 - PMID ?

In primary SP keratinocytes , MG 132 increases expression of SP NODE protein that is decreased by cycloheximide .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 1

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 2

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 3

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 4

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 5

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 6

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 7

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 8

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 9

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 10

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

Analyse 11

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 12

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 13

                                                                             +---------OBJ:V-N--------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 14

       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 15

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

Analyse 16

                                                                     +-------------OBJ:V-N------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 17

       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 18

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 19

                                                         +-------------------OBJ:V-N------------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 20

       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 21

                                                         +-------------------OBJ:V-N------------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 22

                                                         +-------------------OBJ:V-N------------------+                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 23

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                              +---------OBJ:V-N--------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 24

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 25

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                      +-------------OBJ:V-N------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 26

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 27

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

Analyse 28

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 29

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 30

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 31

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 32

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 33

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 34

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 35

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 36

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 37

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 38

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 39

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 40

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |                   +---------OBJ:V-N--------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 41

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 42

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |           +-------------OBJ:V-N------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 43

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 44

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 45

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 46

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

Analyse 47

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 48

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +---------------SUBJ:V-N---------------+     |                       
                                                         +--------COMP:N-N(of)-------+          |     |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 49

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 50

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +---------------SUBJ:V-N---------------+     |                       
                         |                               +--------COMP:N-N(of)-------+          |     |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+          |     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 51

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +--MOD_ATT:N-ADJ--+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 52

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +---------------SUBJ:V-N---------------+     |              |        
                                              |          +--------COMP:N-N(of)-------+          |     |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

Analyse 53

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 54

                                                                             +---------OBJ:V-N--------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 55

       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 56

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

Analyse 57

                                                                     +-------------OBJ:V-N------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 58

       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 59

                                                         +--------COMP:N-N(of)-------+----------COMP:N-N(by)---------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 60

                                                         +--------COMP:N-N(of)-------+                                        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

Analyse 61

                                                         +-------------------OBJ:V-N------------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 62

       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 63

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 64

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 65

                                                         +-------------------OBJ:V-N------------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 66

                                                         +-------------------OBJ:V-N------------------+                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 67

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                              +---------OBJ:V-N--------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 68

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 69

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |                      +-------------OBJ:V-N------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 70

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 71

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,expression)

Analyse 72

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 73

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 74

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 75

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 76

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 77

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 78

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +---------------SUBJ:V-N---------------+     |              |        
                                                         +--------COMP:N-N(of)-------+          |     |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

Analyse 79

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 80

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 81

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                                        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 82

                                                                             +--------------COMP:N-N(by)-------------+        
                                                                             +---------OBJ:V-N--------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 83

                                                                             +--------------COMP:N-N(by)-------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 84

                                                                     +------------------COMP:N-N(by)-----------------+        
                                                                     +-------------OBJ:V-N------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 85

                                                                     +------------------COMP:N-N(by)-----------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 86

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 87

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 88

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |                   +---------OBJ:V-N--------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 89

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 90

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         |           +-------------OBJ:V-N------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 91

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 92

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+-SUBJ:V-N-+     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 93

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 94

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +---------------SUBJ:V-N---------------+     |                       
                                                         +--------COMP:N-N(of)-------+          |     |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 95

                                                         +----------------SUBJ:V_PASS-N---------------+                       
                                                         +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                +COMP:V_PASS-N(+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)
COMP:V_PASS-N(by) (decrease,cycloheximide)

Analyse 96

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 97

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 98

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 99

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +--MOD_ATT:N-ADJ--+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-ADJ (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 100

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +---------------SUBJ:V-N---------------+     |                       
                         |                               +--------COMP:N-N(of)-------+          |     |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+          |     |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+          |     +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 101

                         +--------------------------------COMP:V-N(In)--------------------------------+                       
                         |                               +------------------SUBJ:V-N------------------+                       
                         |                               +--------COMP:N-N(of)-------+                |                       
       +---MOD_ATT:N-N---+             +---MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ-+                |                       
       |       +MOD_ATT:N+             |      +MOD_ATT:N-+           |       +MOD_ATT+                +-COMP:V-N(by)-+        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
MOD_ATT:N-N (expression,@card@)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V-N(In) (decrease,keratinocytes)
SUBJ:V-N (decrease,expression)
COMP:V-N(by) (decrease,cycloheximide)

Analyse 102

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +---------------SUBJ:V-N---------------+     |              |        
                                              |          +--------COMP:N-N(of)-------+          |     |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

Analyse 103

                                              +-----------------------------COMP:V-N(by)-----------------------------+        
                                              |          +----------------SUBJ:V_PASS-N---------------+              |        
                                              |          +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:V-N(by) (increase,cycloheximide)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 104

                                                         +--------COMP:N-N(of)-------+----------COMP:N-N(by)---------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 105

                                                         +--------COMP:N-N(of)-------+                                        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+----------COMP:N-N(by)---------+        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:N-N(by) (protein,cycloheximide)
SUBJ:V_PASS-N (decrease,protein)

Analyse 106

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+--SUBJ:V_PASS-N-+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
SUBJ:V_PASS-N (decrease,protein)

Analyse 107

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +--------COMP:N-N(of)-------+                               |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                               |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+--SUBJ:V_PASS-N-+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,protein)

Analyse 108

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +---------------SUBJ:V-N---------------+     |              |        
                                                         +--------COMP:N-N(of)-------+          |     |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+          |     |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+          |     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,expression)
SUBJ:V_PASS-N (decrease,expression)

Analyse 109

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +----------------SUBJ:V_PASS-N---------------+              |        
                                                         +--------COMP:N-N(of)-------+                |              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |           +-MOD_ATT:N-ADJ-+                |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           |       +MOD_ATT+                |              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,protein)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (decrease,expression)

Analyse 110

                                                                             +--------------COMP:N-N(by)-------------+        
                                                                             +---------OBJ:V-N--------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 111

                                                                             +--------------COMP:N-N(by)-------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+---------OBJ:V-N--------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(by) (__NODE__,cycloheximide)
OBJ:V-N (decrease,__NODE__)
SUBJ:V-N (decrease,protein)

Analyse 112

                                                                     +------------------COMP:N-N(by)-----------------+        
                                                                     +-------------OBJ:V-N------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      |               +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 113

                                                                     +------------------COMP:N-N(by)-----------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+                      +-------------OBJ:V-N------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (__SP__,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,__SP__)
SUBJ:V-N (decrease,protein)

Analyse 114

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          |                           +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 115

                                                         +------------------------COMP:N-N(by)-----------------------+        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +-------------------OBJ:V-N------------------+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+COMP:N-N(of+       +MOD_ATT+----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 116

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+       +----SUBJ:V-N----+              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +-SUBJ:V-N-+     |              |        
       |       |         |             |      |          |           |       |       |          |     |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
SUBJ:V-N (be,protein)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)

Analyse 117

                                                         +------------------------COMP:N-N(by)-----------------------+        
                                                         +-------------------OBJ:V-N------------------+              |        
       +---MOD_ATT:N-N---+----COMP:V-N(In)----+          +----COMP:N-N(of)---+                        |              |        
       |       +MOD_ATT:N+             +SUBJ:V+--OBJ:V-N-+           +MOD_ATT+       +----SUBJ:V-N----+              |        
       |       |         |             |      |          |           |       |       |                |              |        
 In primary __SP__ keratinocytes , MG 132 increases expression of __SP__ __NODE__ protein that is decreased by cycloheximide .
MOD_ATT:N-N (keratinocytes,primary)
MOD_ATT:N-ADJ (keratinocytes,__SP__)
COMP:V-N(In) (increase,keratinocytes)
SUBJ:V-N (increase,@card@)
OBJ:V-N (increase,expression)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(by) (expression,cycloheximide)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (decrease,expression)
SUBJ:V-N (decrease,protein)